跳至主要内容
临床试验/CTRI/2023/07/054608
CTRI/2023/07/054608尚未招募4 期

Efficacy of Surfactant administration through laryngeal or supraglottic airways (SALSA) vs Intubate-Surfactant-Extubate (INSURE) in Preterm Neonates with Respiratory Distress Syndrome: A Randomized Study

Srikanth kandi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年10月7日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1. FiO2 0.3

研究概览

简要总结

Surfactantreplacement therapy is one of the most common procedures performed in the neonatalintensive care unit for preterm neonates. Intubate,Surfactant, Extubate is the most commonly used technique,which involves intubation and may result in ventilator associated lung injury. Surfactant administration through laryngeal andsupraglottic airways is a newer modality in which a supraglottic airway deviceis used to deliver surfactant, thus eliminating the need for intubation and itsadverse effects. We plan to conduct this randomized control trial with non-inferioritystudy design. During the study, we anticipate enrolling at least 20 subjects ineach group, consisting of preterm neonates with respiratory distress syndrome whoreceive surfactant through either of the two techniques. The primary outcome issuccess of surfactant therapy which is defined by the attainment of thefollowing parameters within 60 minutes of administration of surfactant: FiO2<0.3, no/minimal retractions and respiratory rate <80 bpm. The Surfactant administration through laryngeal andsupraglottic airways is anticipated to be non-inferior to conventionaltechnique, however with certain other benefits like ease of delivery, lesserdiscomfort and instability of the neonate. The secondary outcome measures willbe need for invasive ventilation within 72 hours of surfactant delivery, numberof doses of surfactant required, total time taken to perform the procedure,gastric leakage of surfactant, cumulative duration of respiratory support (bothinvasive and non-invasive) during hospital stay, total duration of thefollowing events during and within 10 minutes after delivery of surfactant - apnea,preductal oxygen saturation <85% and heart rate less than 100 bpm, incidenceof pneumothorax, bronchopulmonary dysplasia and intraventricular hemorrhage,Neonatal pain assessment will be done using Neonatal-Pain Agitation and SedationScale and proceduralist stress scorewill be assessed by Likert scale.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
0.00 Day(s) 至 28.00 Day(s)(—)
性别
All

入选标准

  • Preterm neonates with respiratory distress syndrome on CPAP with requirement of FiO2 >0.3 and PEEP of 6cm H2O or more.

排除标准

  • Neonates intubated before enrolment Major congenital malformations Refusal to participate.

结局指标

主要结局

1. FiO2 0.3

时间窗: 60 minutes after surfactant delivery

Success of surfactant delivery: attainment of following parameters within 60 minutes of delivery of Surfactant:

时间窗: 60 minutes after surfactant delivery

2. No / mild retractions

时间窗: 60 minutes after surfactant delivery

3. RR: 80 bpm

时间窗: 60 minutes after surfactant delivery

次要结局

  • Need for invasive ventilation during 72 hrs following surfactant delivery(Number of doses of surfactant required)

研究者

发起方
Srikanth kandi
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验